Should men over the age of 65 years receive PSA screening? Argument in favor
Jared M Whitson* and Badrinath R Konety
Correspondence *University of California San Francisco, Department of Urology, 400 Parnassus Avenue, A-631, San Francisco, CA 94143, USA
Email jwhitson@urology.ucsf.edu
Whether or not men over the age of 65 years should receive PSA screening for prostate cancer is a controversial issue. In this first of two Viewpoints on the topic, Whitson and Konety argue that men over 65 years old can have clinically relevant prostate cancer, that they can benefit from prostate cancer treatment, and that PSA screening is warranted in these men.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.